OGen Price history and pattern movenent

2:53p ET 7/27/2021 - Benzinga

Why Did Oragenics Shares Skyrocket Tuesday?

Mentioned:

OGEN

Oragenics Inc. (NYSE: OGEN) shares skyrocketed higher Tuesday after the company entered into a licensing agreement with the National Research Council of Canada to pursue the rapid development of next-generation SARS-CoV-2 vaccines.

This platform should allow productions of cell lines within six to eight weeks compared to six to nine months for traditional production.

Oragenics was up 38.33% at 86 cents at last check.

Oragenics Daily Chart Analysis

• Shares have been falling in the last few months, but just broke out of what technical traders would call a falling wedge pattern.
• The stock crossed above both the 50-day moving average (green), and the 200-day moving average, indicating sentiment in the stock started turning bullish.
• These moving averages may both hold as an area of support in the future.

• See also: Best Healthcare Penny Stocks

Key Oragenics Levels To Watch

• The stock shot higher out of the pattern after it got the vaccine news today. The stock may see consolidation in the coming days.
• Tuesday, it looks like the stock had trouble getting above the $1 level; this potentially could be a place of resistance in the future but it is likely still too early to call. The $1 level is a psychological resistance level for many traders who trade sub-$1 stocks.
• The Relative Strength Index (RSI) shot higher Tuesday and now sits at 76 on the indicator. This puts it in the overbought range, showing there has been a large influx of buyers since the news was released.

What's Next For Oragenics?

Bullish traders would like to see the stock continue to rise until it runs out of gas, and then consolidate while holding some of the gains it made from the run. Consolidation is key to see if the stock is ready to make another leg up.

Bearish traders would like to see the stock fall and be unable to hold the gains from the breakout. This could mean that the stock is not ready for its next leg up. Bears would also like to see the stock fall back below the moving averages for a potential change in sentiment and trend.

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

OGEN PRICE PATTERN AS OF MARCH 02 2021

OGEN PRICE PATTERN OF FEBRUARY 24 TO MARCH 02 2021

 On Dec 02 2020 sold at 0.555 4202share (2332.11)@10.49am (no event)

On Dec 20 2020 sold at 0.50  10000share (5000$) @2:41pm

On Dec 23 2020 sold at 0.60 2000 share   (1200$) @6:02am

On Jan 20 2021 sold at 1.12 4000 share    (4481$)  @12:59pm

On Jan get in at 1.03$ dollar again 

on Feb 08 2021 it went up til 1.43 on day  (volume 85.97million ) 

on Feb 09 2021 it went up til  1.80 on day (volume 64.63million)

Gradually coming down from  1.38 premarket on feb 24 2021 

 going down from

1.20 , 

1.16.

1.10.

1.05

0.99 

0.9802  lowest for the week

 

 

OGEN Trade table

 

2:53p ET 7/27/2021 - Benzinga

Why Did Oragenics Shares Skyrocket Tuesday?

Mentioned:

OGEN

Oragenics Inc. (NYSE: OGEN) shares skyrocketed higher Tuesday after the company entered into a licensing agreement with the National Research Council of Canada to pursue the rapid development of next-generation SARS-CoV-2 vaccines.

This platform should allow productions of cell lines within six to eight weeks compared to six to nine months for traditional production.

Oragenics was up 38.33% at 86 cents at last check.

Oragenics Daily Chart Analysis

• Shares have been falling in the last few months, but just broke out of what technical traders would call a falling wedge pattern.
• The stock crossed above both the 50-day moving average (green), and the 200-day moving average, indicating sentiment in the stock started turning bullish.
• These moving averages may both hold as an area of support in the future.

• See also: Best Healthcare Penny Stocks

Key Oragenics Levels To Watch

• The stock shot higher out of the pattern after it got the vaccine news today. The stock may see consolidation in the coming days.
• Tuesday, it looks like the stock had trouble getting above the $1 level; this potentially could be a place of resistance in the future but it is likely still too early to call. The $1 level is a psychological resistance level for many traders who trade sub-$1 stocks.
• The Relative Strength Index (RSI) shot higher Tuesday and now sits at 76 on the indicator. This puts it in the overbought range, showing there has been a large influx of buyers since the news was released.

What's Next For Oragenics?

Bullish traders would like to see the stock continue to rise until it runs out of gas, and then consolidate while holding some of the gains it made from the run. Consolidation is key to see if the stock is ready to make another leg up.

Bearish traders would like to see the stock fall and be unable to hold the gains from the breakout. This could mean that the stock is not ready for its next leg up. Bears would also like to see the stock fall back below the moving averages for a potential change in sentiment and trend.

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Table1

ID	STOCK	PRICES	AMOUNT	Field1	number	fill prices	fill dollar	total filled	total unit	average	Field3	Field2	Field4	Field5	Field6
59	OGEN	$0.67	4391	$2,941.97	4000	$0.43	$1,720.00	$4,661.97	8391	$0.56	TD		0

OGEN movement 12/02/2020

OGEN Suddenly goes up at 10:40am from 0.42 to 0.63 and went down back to 50cent 

sell off from RH 4202 share and filled again at TD ameritrade 1000 share total amount 4393share avg is 0.67share . plan to fill 2000 share more in TD

 

OGEN (FILL THE SHORT) POTENTIAL (TD) can exit

As of today OGEN 02/19/2021 OPEN AT 1.26 HIGHEST 1.34 LOWEST AT 1.22 VOLUME 8.19M MARKET CAP 128.54

Oragenics Inc (NYSE American:OGEN)

The 1 analysts offering 12-month price forecasts for Oragenics Inc have a median target of 2.50, with a high estimate of 2.50 and a low estimate of 2.50. 

 

If you are looking for stocks with good return, Oragenics, Inc. stock can be a bad, high-risk 1-year investment option.  

 

Oragenics, Inc. real time quote is equal to 0.394 USD at 2020-11-27, but your current investment may be devalued in the future.

 

The median estimate represents a +509.76% increase from the last price of 0.41.

FILL THE SHORT TABLE as of 11/30/2020

FILL THE SHORT TABLE

ID	STOCK	Field3	PRICES	AMOUNT	Field1	number	fill prices	fill dollar	total filled	total unit	average	NET LOSS	Field2	REMARK
140	OGEN		$0.71	3391	$2,407.61	6000	$0.42	$2,520.00	$4,927.61	9391	$0.52	0	4CENT GAP

 

ID	STOCK	Field3	PRICES	AMOUNT	Field1	number	fill prices	fill dollar	total filled	total unit	average	NET LOSS	Field2	REMARK
140	OGEN	TD	$0.71	3391	$2,407.61	2000	$0.42	$840.00	$3,247.61	5391 share  the volume getting  bigger	$0.60	970	0.18$  x5391 =970 short (0.71$-0.42$)	Net loss 970 but the avg getting closer to the current prices

OGEN push

 

OGEN FILL THE SHORT

 

Is it worth to cover the short ? In order to cover the short 894 $ you have to filled 8460 $ 

Look at the logic 1:10 times to cover the short

ID	STOCK	PRICES	AMOUNT	Field1	number	fill prices	fill dollar	total filled	total unit	average	Field3	Field2
64	OGEN	$0.85	2391	$2,020.63	1000	$0.47	$470.00	$2,490.63	3391	$0.73	0
65	OGEN	$0.85	2391	$2,020.63	2000	$0.47	$940.00	$2,960.63	4391	$0.67	0
66	OGEN	$0.85	2391	$2,020.63	3000	$0.47	$1,410.00	$3,430.63	5391	$0.64	0
67	OGEN	$0.85	2391	$2,032.35	4000	$0.47	$1,880.00	$3,912.35	6391	$0.61	0
68	OGEN	$0.85	2391	$2,032.35	5000	$0.47	$2,350.00	$4,382.35	7391	$0.59	0
69	OGEN	$0.85	2391	$2,032.35	10000	$0.47	$4,700.00	$6,732.35	12391	$0.54	0
70	OGEN	$0.85	2391	$2,032.35	15000	$0.47	$7,050.00	$9,082.35	17391	$0.52	0
71	OGEN	$0.85	2391	$2,032.35	18000	$0.47	$8,460.00	$10,492.35	20391	$0.51	0

Oragenics

 2:53p ET 7/27/2021 - Benzinga

Why Did Oragenics Shares Skyrocket Tuesday?

Mentioned:

OGEN

Oragenics Inc. (NYSE: OGEN) shares skyrocketed higher Tuesday after the company entered into a licensing agreement with the National Research Council of Canada to pursue the rapid development of next-generation SARS-CoV-2 vaccines.

This platform should allow productions of cell lines within six to eight weeks compared to six to nine months for traditional production.

Oragenics was up 38.33% at 86 cents at last check.

Oragenics Daily Chart Analysis

• Shares have been falling in the last few months, but just broke out of what technical traders would call a falling wedge pattern.
• The stock crossed above both the 50-day moving average (green), and the 200-day moving average, indicating sentiment in the stock started turning bullish.
• These moving averages may both hold as an area of support in the future.

• See also: Best Healthcare Penny Stocks

Key Oragenics Levels To Watch

• The stock shot higher out of the pattern after it got the vaccine news today. The stock may see consolidation in the coming days.
• Tuesday, it looks like the stock had trouble getting above the $1 level; this potentially could be a place of resistance in the future but it is likely still too early to call. The $1 level is a psychological resistance level for many traders who trade sub-$1 stocks.
• The Relative Strength Index (RSI) shot higher Tuesday and now sits at 76 on the indicator. This puts it in the overbought range, showing there has been a large influx of buyers since the news was released.

What's Next For Oragenics?

Bullish traders would like to see the stock continue to rise until it runs out of gas, and then consolidate while holding some of the gains it made from the run. Consolidation is key to see if the stock is ready to make another leg up.

Bearish traders would like to see the stock fall and be unable to hold the gains from the breakout. This could mean that the stock is not ready for its next leg up. Bears would also like to see the stock fall back below the moving averages for a potential change in sentiment and trend.

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Why Oragenics Stock Is Trading Higher Today

10:35 am ET October 6, 2020 (Benzinga) Print

Oragenics (NYSE: OGEN) shares are trading higher on Tuesday after the company announced the FDA broadly supports its pre-IND development program for its SARS-CoV-2 vaccine.

Oragenics is focused on becoming a leader in developing novel antibiotics against infectious disease and on developing effective treatments for oral mucositis. Oragenics involves developing its antibiotic product candidate, OG716 as well as other homolog antibiotic product candidates, researching LBPs, and have other product candidates, including SMaRT Replacement Therapy positioned for out-licensing or partnering.

Oragenics shares traded up 8.26% to 65 cents on Tuesday. The stock has a 52-week high of $2.09 and a 52-week low of 36 cents.

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

filled the short

ID	STOCK	PRICES	AMOUNT	Field1	number	fill prices	fill dollar	total filled	total unit	average	Field3	date	time
38	OGEN	$1.03	1591	$1,644.14	1000	$0.48	$480.00	$2,124.14	2591	$0.82	0
39	OGEN	$0.82	2591	$2,124.62	600	$0.48	$288.00	$2,412.62	3191	$0.76	0